• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Hoya picks up Performance Optics for $476m

Hoya picks up Performance Optics for $476m

October 12, 2016 By Fink Densford

HoyaUPDATED Oct. 13, 2016, with details on acquisition amount.

Hoya Corp. (TYO:7741) said today it inked a deal to buy Performance Optics and its subsidiaries Vision Ease and Daemyung Optical for roughly $476 million.

The ¥48.98 billion acquisition includes Performance Optics’ ophthalmic lens manufacturing business, which includes polycarbonate, photochromic, polarized and high index eyeglass lenses, according to Tokyo-based Hoya.

“The acquisition of Performance Optics expands Hoya’s customer reach, particularly through Vision Ease’s presence in the Americas and its strengths in polycarbonate products and technologies. Performance Optics provides Hoya with additional capabilities in polycarbonate, photochromic and polarized lens technologies, as well as an expansion of our global footprint in high index lens casting to reinforce our position as a global technology leader in lens manufacturing. Importantly, we also will augment our global research & development capabilities, creating a new technology center of excellence outside of Japan,” Hoya Vision Care CEO Girts Cimermans said in a press release.

Performance Optics employs 2,000 people worldwide and has manufacturing facilities in the U.S., Korea, Thailand and Indonesia

“Performance Optics’ subsidiaries, Vision Ease and Daemyung Optical, have capabilities and cultures of innovation, quality and service that strongly complement Hoya’s footprint and long-standing reputation in the eyewear industry. By joining forces, we will better meet our customers’ global needs across geographies,” Performance Optics CEO John Weber said in prepared remarks.

“Our acquisition of Performance Optics continues Hoya’s strategic initiatives in the life care segment. Performance Optics enables Hoya to become a more broad-based leader in Vision Care, our largest division,” Hoya Corp chief legal officer Augustine Yee said in a prepared statement.

Hoya shares closed down -1.4% at ¥4,050 apiece ($39.36) in Tokyo Oct. 13.

($1 = ¥102.9)

Material from Reuters was used in this report.

Filed Under: Mergers & Acquisitions, Optical/Ophthalmic, Wall Street Beat Tagged With: Hoya Corp., Performance Optics

More recent news

  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy